Inferring clinically relevant molecular subtypes of pancreatic cancer from routine histopathology using deep learning
Researchers have developed a deep learning model called PanSubNet that can identify molecular subtypes of pancreatic cancer directly from routine histology slides. This tool offers a faster, more cost-effective alternative to traditional transcriptomic sequencing for determining prognosis and treatment paths.
Why it matters
It provides a scalable way to personalize cancer treatment by leveraging existing diagnostic images, potentially improving outcomes for patients with aggressive pancreatic tumors.
Communications Medicine ( 2026 ) Cite this article
We’re sharing this article early to provide faster access to peer-reviewed, accepted research. It is citable and carries a permanent DOI. This version is subject to further edits and will be replaced automatically by the final Version of Record. All legal disclaimers apply.
Pancreatic ductal adenocarcinoma comprises classical and basal-like molecular subtypes that differ in prognosis and treatment response. However, transcriptomic subtyping is limited by cost, turnaround time, and tissue requirements. We aimed to determine whether these molecular phenotypes can be inferred directly from routine hematoxylin and eosin–stained whole-slide images using deep learning.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in